HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Martelletti Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

11/2021Coronavirus disease 2019 in patients with cardiovascular disease: clinical features and implications on cardiac biomarkers assessment.
6/2021Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paolo Martelletti Research Topics

Disease

130Migraine Disorders (Migraine)
05/2024 - 05/2002
48Headache (Headaches)
12/2023 - 04/2005
21Pain (Aches)
01/2024 - 01/2004
13COVID-19
11/2023 - 01/2020
8Cluster Headache (Cluster Headaches)
05/2020 - 11/2011
7Secondary Headache Disorders
11/2023 - 04/2006
7Prescription Drug Overuse
11/2022 - 12/2011
7Epilepsy (Aura)
05/2020 - 05/2002
6Headache Disorders (Headache Syndromes)
05/2019 - 12/2006
4Pneumonia (Pneumonitis)
04/2022 - 11/2020
4Ischemic Stroke
01/2020 - 02/2007
3Inflammation (Inflammations)
04/2022 - 02/2007
3Mood Disorders (Mood Disorder)
12/2021 - 08/2009
3Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 11/2020
3Infections
01/2021 - 01/2020
3Migraine with Aura (Familial Hemiplegic Migraine)
10/2017 - 05/2002
2Neck Pain (Cervicalgia)
01/2023 - 12/2022
2Substance-Related Disorders (Drug Abuse)
01/2022 - 04/2021
2Chronic Obstructive Pulmonary Disease (COPD)
11/2021 - 06/2021
2Post-Traumatic Headache
05/2020 - 01/2004
2Neurogenic Inflammation
05/2020 - 08/2019
2Acute Pain
01/2015 - 01/2015
2Tension-Type Headache (Tension Headache)
10/2014 - 02/2007
2Mental Disorders (Mental Disorder)
02/2014 - 08/2009
1Injection Site Reaction
11/2023

Drug/Important Bio-Agent (IBA)

28Calcitonin Gene-Related PeptideIBA
01/2024 - 10/2009
27Type A Botulinum Toxins (Botox)FDA Link
12/2023 - 01/2004
26Tryptamines (Triptans)IBA
10/2022 - 09/2008
24Monoclonal AntibodiesIBA
02/2024 - 02/2015
15Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
02/2024 - 06/2012
7Biomarkers (Surrogate Marker)IBA
07/2023 - 09/2009
7lasmiditanIBA
07/2023 - 09/2012
6fremanezumabIBA
01/2024 - 12/2018
6preemptIBA
12/2023 - 12/2011
6Serotonin (5 Hydroxytryptamine)IBA
01/2023 - 02/2014
6erenumabIBA
06/2022 - 01/2017
6Sumatriptan (Imigran)FDA LinkGeneric
10/2014 - 09/2008
5Topiramate (Topamax)FDA LinkGeneric
07/2023 - 07/2010
5Valproic Acid (Depakote)FDA LinkGeneric
07/2023 - 07/2010
5galcanezumabIBA
06/2022 - 02/2015
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2021 - 10/2009
5Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
05/2020 - 06/2012
5Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2020 - 01/2004
5salicylhydroxamic acid (SHAM)IBA
01/2019 - 01/2018
5Pain-FreeIBA
11/2018 - 06/2011
4Peptides (Polypeptides)IBA
11/2023 - 10/2009
45-HT1F Serotonin ReceptorIBA
01/2023 - 02/2015
4eptinezumabIBA
06/2022 - 02/2015
4TroponinIBA
04/2022 - 11/2020
4KynurenineIBA
12/2015 - 01/2015
4almotriptan (Axert)FDA Link
05/2013 - 06/2011
3Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
02/2024 - 01/2018
3Calcitonin (Calcitonin, Eel)FDA LinkGeneric
11/2023 - 08/2019
3fibrin fragment D (D-dimer)IBA
04/2022 - 11/2020
3VaccinesIBA
03/2022 - 01/2020
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2022 - 02/2007
3Hormones (Hormone)IBA
12/2021 - 05/2014
3Natriuretic PeptidesIBA
11/2021 - 11/2020
3ubrogepantIBA
05/2021 - 01/2019
3Analgesics (Analgesic Drugs)IBA
04/2021 - 01/2015
3Contraceptive Agents (Contraceptives)IBA
01/2020 - 10/2017
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 01/2004
3Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA
01/2018 - 09/2012
3Glutamic Acid (Glutamate)FDA Link
06/2015 - 10/2009
3Anticonvulsants (Antiepileptic Drugs)IBA
08/2014 - 07/2010
3frovatriptan (Allegro)FDA Link
07/2012 - 06/2011
3telcagepantIBA
06/2012 - 09/2008
3olcegepantIBA
06/2012 - 09/2008
2N-Methylaspartate (NMDA)IBA
01/2024 - 01/2021
2AntibodiesIBA
11/2023 - 01/2020
2atogepantIBA
11/2023 - 05/2021
2Orexin Receptor AntagonistsIBA
07/2023 - 09/2012
2Illicit Drugs (Recreational Drugs)IBA
01/2022 - 08/2009
2Estrogens (Estrogen)FDA Link
12/2021 - 08/2018
2rimegepant sulfateIBA
05/2021 - 01/2019
2Glutamate Receptors (Glutamate Receptor)IBA
01/2021 - 02/2015
2Neurotransmitter Agents (Neurotransmitter)IBA
10/2020 - 08/2019
2Dehydroepiandrosterone (DHEA)IBA
05/2019 - 04/2006
2Botulinum Toxins (Botulinum Toxin)IBA
03/2019 - 09/2017
2Serotonin ReceptorsIBA
01/2018 - 02/2015
2tonabersatIBA
09/2012 - 10/2009
21- (N(2)- (3,4- dibromo- N- ((4- (3,4- dihydro- 2(1H)- oxoquinazolin- 3- yl)- 1- piperidinyl)carbonyl)tyrosyl)lysyl)- 4- (4- pyridinyl)piperazineIBA
10/2009 - 09/2008
1Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
02/2024
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
02/2024
1nirmatrelvirIBA
11/2023
1Ritonavir (Norvir)FDA Link
11/2023
1CytochromesIBA
11/2023
1nirmatrelvir and ritonavir drug combinationIBA
11/2023
1Cytochrome P-450 CYP3AIBA
11/2023

Therapy/Procedure

49Therapeutics
05/2024 - 01/2004
10Drug Therapy (Chemotherapy)
01/2021 - 01/2004
6Vagus Nerve Stimulation
01/2019 - 10/2013
5Contraindications
11/2023 - 01/2019
4Polypharmacy
01/2023 - 09/2020
3Transcutaneous Electric Nerve Stimulation (TENS)
08/2023 - 01/2004
3Precision Medicine
08/2022 - 01/2018
3Contraception (Birth Control)
10/2018 - 10/2017
2Physical Therapy Modalities (Physical Therapy Technique)
08/2023 - 01/2023
2Injections
05/2020 - 12/2006
2Aftercare (After-Treatment)
10/2018 - 09/2015